These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 392214)

  • 21. The role of suppressor cells in the pathogenesis of common variable hypogammaglobulinemia and the immunodeficiency associated with myeloma.
    Waldmann TA; Broder S; Krakauer R; MacDermott RP; Durm M; Goldman C; Meade B
    Fed Proc; 1976 Jul; 35(9):2067-72. PubMed ID: 1084293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polyclonal activation of murine B lymphocytes by Fc fragments. I. The requirement for two signals in the generation of the polyclonal antibody response induced by Fc fragments.
    Morgan EL; Weigle WO
    J Immunol; 1980 Mar; 124(3):1330-5. PubMed ID: 6965691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cross-reactivity of T-cell 'helper' function.
    Birnbaum G; Weksler ME; Siskind GW
    Clin Exp Immunol; 1974 Sep; 18(1):55-61. PubMed ID: 4143197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of proliferation of a murine myeloma cell line and mitogen-stimulated B lymphocytes by the antibiotic amphotericin B (Fungizone).
    Walls EV; Kay JE
    Immunology; 1982 Sep; 47(1):115-21. PubMed ID: 6981585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specific immunosuppression of antibody responses by an antiserum against a T-cell factor.
    Gorczynski RM; Miller RG; Phillips RA
    Transplant Proc; 1973 Mar; 5(1):607-9. PubMed ID: 4572119
    [No Abstract]   [Full Text] [Related]  

  • 26. Histometric analysis of the chicken spleen during primary immune response to soluble bovine serum albumin. III. Effect of antigen dose on proliferation of immunologically competent cells using optimal and large quantities of antigen.
    Nagy ZA; Fehér G
    Z Immunitatsforsch Exp Klin Immunol; 1972 May; 143(4):323-32. PubMed ID: 4282917
    [No Abstract]   [Full Text] [Related]  

  • 27. Clonal competition and stability of hybrid myelomas of mouse and rat origin.
    Galfré G; Butcher GW; Howard JC; Wide CD; Milstein C
    Transplant Proc; 1980 Sep; 12(3):371-5. PubMed ID: 6784297
    [No Abstract]   [Full Text] [Related]  

  • 28. Role of T-cell antigen-specific factor in T-B cooperation.
    Feldmann M
    Transplant Proc; 1973 Mar; 5(1):111-4. PubMed ID: 4540461
    [No Abstract]   [Full Text] [Related]  

  • 29. T-cell hybrids as a source of antigen-specific factors.
    Taussig MJ; Holliman A; Corvalán JR
    Transplant Proc; 1980 Sep; 12(3):427-31. PubMed ID: 6164137
    [No Abstract]   [Full Text] [Related]  

  • 30. Adoptive transfer of spleen cells from mice treated with radioactive strontium: suppressor cells, natural killer cells, and "hybrid resistance" in recipient mice.
    Levy EM; Bennett M; Kumar V; Fitzgerald P; Cooperband SR
    J Immunol; 1980 Feb; 124(2):611-8. PubMed ID: 6444313
    [No Abstract]   [Full Text] [Related]  

  • 31. Antibody production by hybridomas.
    Goding JW
    J Immunol Methods; 1980; 39(4):285-308. PubMed ID: 7007515
    [No Abstract]   [Full Text] [Related]  

  • 32. Various forms of specialization in cells which synthesize immunoglobulins.
    Nossal GJ
    Ann Immunol (Paris); 1974 Jan; 125C(1-2):239-51. PubMed ID: 4376660
    [No Abstract]   [Full Text] [Related]  

  • 33. Isolation and characterization of a myeloma--spleen-cell hybrid producing antibody to phenylalanine hydroxylase.
    Cotton RG; Jennings IG; Choo KH; Fowler K
    Biochem J; 1980 Dec; 191(3):777-83. PubMed ID: 6793035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Production and screening of cell hybrids producing a monoclonal antibody to human interferon-alpha.
    Morser J; Meager A; Burke DC; Secher DS
    J Gen Virol; 1981 Apr; 53(Pt 2):257-65. PubMed ID: 6167666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mouse myeloma--spleen cell hybrids: Enhanced hybridization frequencies and rapid screening procedures.
    Claflin L; Williams K
    Curr Top Microbiol Immunol; 1978; 81():107-9. PubMed ID: 567553
    [No Abstract]   [Full Text] [Related]  

  • 36. A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines.
    Kearney JF; Radbruch A; Liesegang B; Rajewsky K
    J Immunol; 1979 Oct; 123(4):1548-50. PubMed ID: 113458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fusion of T and B cells.
    Köhler G; Pearson T; Milstein C
    Somatic Cell Genet; 1977 May; 3(3):303-12. PubMed ID: 305123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High efficiency of Biozzi's high responder mouse strain in the generation of antibody secreting hybridomas.
    Boumsell L; Bernard A
    J Immunol Methods; 1980; 38(3-4):225-9. PubMed ID: 7192298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monoclonal antibodies against human cell membrane antigens: a review.
    Zola H
    Pathology; 1980 Oct; 12(4):539-57. PubMed ID: 7008006
    [No Abstract]   [Full Text] [Related]  

  • 40. Plaque morphology studied with immune hybridomas.
    Bussard AE
    Mol Immunol; 1980 Jan; 17(1):57-63. PubMed ID: 6987488
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.